MIRMedMiraMIR info
$0.05info-6.25%24h
Global rank25400
Market cap$36.32M
Change 7d-16.67%
YTD Performance-31.82%
SP500 benchmarkUnderperform
P/E-13.02
P/S120.94
Revenue$300.30K
Earnings-$1.86M
Dividend yield-
Main Sector
Healthcare

MedMira (MIR) Stock Overview

MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally. The company offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product to perform preliminary screening of HIV and hepatitis. It also provides Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. In addition, the company offers VYRATM TriDemic antigen rapid test that distinguishes the three respiratory viruses, such as SARS-CoV-2, influenza, and respiratory syncytial virus that exhibit similar symptoms. It sells its products through a network of medical distributors and strategic business development partners to customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.

MIR Stock Information

Symbol
MIR
Address
155 Chain Lake DriveHalifax, NS B3S 1B3Canada
Founded
-
Trading hours
-
Website
https://www.medmira.com
Country
🇨🇦 Canada
Phone Number
902 450 1588

MedMira (MIR) Price Chart

-
Value:-

MedMira Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.052072486981878774
N/A
Market Cap
$36.32M
N/A
Shares Outstanding
697.45M
0.00%
Employees
0
N/A
Shareholder Equity
-15.03M
21.65%
Valuation
2023
Change
P/E Ratio
-13.02
N/A
P/S Ratio
120.94
N/A
P/B Ratio
-2.42
N/A
Growth
2023
Change
Return on Equity
0.1236
N/A
Earnings
2023
Change
Revenue
$300.30K
N/A
Earnings
-$1.86M
N/A
EPS
-0.004
N/A
Earnings Yield
-0.0768
N/A
Gross Margin
0.6945
N/A
Operating Margin
-4.11
N/A
Net income margin
-6.19
N/A
Financial Strength
2023
Change
Total Assets
$2.54M
N/A
Total Debt
$6.44M
N/A
Cash on Hand
$9.15K
N/A
Debt to Equity
-0.8630
-5.11%
Cash to Debt
0.0014
-64.75%
Current Ratio
0.1076
-8.27%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org